David Hallengärd

David Hallengärd worked at Mabtech AB as the Head of Antibody Lead Generation from February 2021 to present, and as a Team Leader in R&D from June 2017 to February 2021. Before Mabtech, they worked as a Scientist at Affibody AB from February 2016 to June 2017, at Cepheid from August 2015 to February 2016, and at BioArctic AB from May 2014 to June 2015. David started their career at Karolinska Institutet, where they held various roles including Postdoctoral Researcher from December 2011 to May 2014, PhD student from April 2008 to December 2011, and Researcher from July 2007 to April 2008.

David Hallengärd received a Ph.D. in an unspecified field from Karolinska Institutet in 2011. Between 2008 and 2010, they obtained a Med.Lic. degree from the same institution. Prior to that, they completed their M.Sc. in Molecular biology at Stockholm University from 2003 to 2007.